Myasthenia Gravis
Non-neuronal cholinergic activity is potentiated in myasthenia gravis
... the Myasthenia Gravis Foundation of America (MGFA) clinical classification, and the severity of disease and effectiveness of treat- ment were assessed by a validated quantitative MG Scoring system (QMG ...
9
China guidelines for the diagnosis and treatment of myasthenia gravis
... Myasthenia gravis (MG) is neuromuscular disorder induced neurotransmission defects at the neuromuscular junctions. MG is an autoimmune disease in which the autologous immune system, including the ...
9
Laparoscopic Sleeve Gastrectomy in a Morbidly Obese Patient with Myasthenia Gravis: A Review of the Management
... Myasthenia gravis, a disorder of neuromuscular transmission, presents a unique challenge to the perioperative anesthetic management of morbidly obese ...for myasthenia gravis and fatty liver ...
5
Psychopharmacology in myasthenia gravis patients with focus on depression
... Myasthenia gravis is an autoimmune disease with a potential to disrupt brain function and cause depression as a result of the disease itself or treatment side ...between myasthenia gravis and ...
5
Assessment of cognitive function in patients with myasthenia gravis
... Aim: During the past decade, there has been an increasing interest in the evaluation of cognitive function in myasthenia gravis (MG), neuromuscular transmission disorder caused by acetylcholine receptor ...
6
Thymectomy in Children with Juvenile Myasthenia Gravis: Is It Recommended?
... Objective: Juvenile myasthenia gravis (JMG) is a rare disease with possible severe forms. Thymectomy is supported by many authors particularly in generalised forms with positive AcetylCholine Receptor ...
9
Effect of Diaphragm Plication in Thymoma Patients with and without Myasthenia Gravis
... A retrospective cohort study was performed on 26 patients with thymoma; half of the patients had myasthenia gravis and the other half did not have myasthenia gravis. All patients underwent ...
6
HLA antigens in Japanese patients with myasthenia gravis
... HLA antigens in 104 Japanese patients and 41 families with myasthenia gravis (MG) were investigated. The frequencies of DR9 and DRw13 were significantly increased in the patients who developed MG before 3 ...
9
Current and emerging treatments for the management of myasthenia gravis
... Myasthenia gravis (MG) is a neuromuscular disorder characterized by a clinical course of fluctuating, painless muscle weakness. Typically it begins in the extraocular muscles and remains purely ocular in ...
11
Myasthenia gravis in a professional cyclist—A case report
... A 22-year-old professional bicycle rider presented to the thoracic surgery department at our hospital with a mediastinal tumor detected on a routine medical exami- nation. His chest X-ray, CT and MRI (Figure 1) indi- ...
5
The Emerging Potentials of Human Regulatory B Cells Mediated Therapies in Myasthenia Gravis.
... of myasthenia gravis which can be in the following methods, such as method (1) Bregs phenotypic identification in isolated B cells from MG patient-derived PBMCs and in vitro expansion in drug medium and ...
14
Regulatory T cells in multiple sclerosis and myasthenia gravis
... autoimmune myasthenia gravis; FoxP3: Forkhead box P3; GBS: Guillain-Barre syndrome; GC: Germinal center; GCN2: General control nonderepressible 2; GM-CSF: Granulocyte macrophage-colony stimulating factor; ...
16
EFFECTS OF ADRENOCORTICOTROPHIC HORMONE ON NEURO MUSCULAR FUNCTION IN PATIENTS WITH MYASTHENIA GRAVIS
... The adrenocorticotrophic hormone of the pituitary gland has been administered to patients with myasthenia gravis mainly on the basis of the following observations and inferences: 1 the i[r] ...
9
Anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor GluR2 encephalitis in a myasthenia gravis patient with complete thymectomy: a case report
... reported to be associated with AE, the most com- mon targets are LGI1, Caspr2 and γ-aminobutyric acid (GABA)- A type receptor antibody encephalitis [2–5]. Thymoma-associated encephalitis associated with ...
5
Thymectomy for non-thymomatous myasthenia gravis: a propensity score matched study
... In our center, thymectomy for non-thymomatous MG, is usually performed in patients with generalized MG who are young, and therefore most frequently women. Given this clear bias by indication, where base- line ...
8
Progressive cutaneous Cryptococcosis complicated with meningitis in a myasthenia gravis patient on long term immunosuppressive therapy – a case report
... MG is an autoimmune disease with auto-antibodies that attack specific receptors located on the surface of muscle cells preventing acetylcholine from binding to them, and thus, preventing the muscle from responding to the ...
7
Myasthenia gravis
... Myasthenia gravis (MG) is a rare, autoimmune neuromuscular junction disorder. Contemporary prevalence rates approach 1/5,000. MG presents with painless, fluctuating, fatigable weakness involving specific ...
13
Current and emerging therapies for the treatment of myasthenia gravis
... Abstract: Myasthenia gravis (MG) is an autoimmmune disease in which autoantibodies to different antigens of the neuromuscular junction cause the typical weakness and ...
10
MANAGEMENT OF MYASTHENIA GRAVIS IN PREGNANCY
... As with several autoimmune diseases, myasthenia gravis (MG) occurs frequently in young women in their childbearing years. The treatment of MG in women therefore poses unique and challenging issues to ...
15
Advances in Research on the Relationship Between Intestinal Flora and Myasthenia Gravis
... of Myasthenia Gravis is different from that of healthy ...autoimmune Myasthenia Gravis animal ...and Myasthenia Gravis, to provide new ideas for further study of the pathogenesis ...
19